TIRZEPATIDE TREATMENT AND ASSOCIATED CHANGES IN β-CELL FUNCTION AND INSULIN SENSITIVITY IN PEOPLE WITH OBESITY OR OVERWEIGHT WITH PREDIABETES OR NORMOGLYCEMIA: A POST HOC ANALYSIS FROM THE SURMOUNT-1 TRIAL

Descargar Publicación
Benefit of Semaglutide in Symptomatic Peripheral Artery Disease by Baseline Type 2 Diabetes Characteristics: Insights From STRIDE, a Randomized, Placebo-Controlled, Double-Blind Trial Health Expenditures Decline After Bariatric Surgery for Patients With Type 2 Diabetes